Ionis Pharmaceuticals Inc (IONS)

NASDAQ · Biotechnology

59.13
+0.50 (+0.85%)
Updated Aug 18, 6:01 PM ET
AI Rating
Hold
Overall Score
44
Trend
25
Momentum
59
Risk
52

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 20, 2026 120 sessions Aug 14, 2026

AI Analysis

Ionis Pharmaceuticals Inc is trading at $59.13, up 0.85% on the session. The 50 day average sits at $66.28 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 45, which reads as weak, and MACD is bullish crossover. Volume is below average.

The nearest support is around $52.82 with resistance near $57.48, so that band frames the current range. Average daily movement is roughly $2.27, or about 3.8% of the share price, which is what any stop placement has to allow for. The overall health score of 44 out of 100 combines a trend score of 25, momentum of 59 and a risk score of 52.

Technical indicators

RSI (14)
45.0
weak
MACD
-2.733
bullish crossover
SMA 20
55.08
SMA 50
66.28
SMA 200
--
unknown
ATR (14)
2.27
avg daily range
Support
52.82
Resistance
57.48
Volume vs 20d
0.50x
below average
Volatility
39.5%
annualised
1 month
+4.21%
3 months
-24.52%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.